BLFS — BioLife Solutions Share News
0.000.00%
Last trade - 00:00- $1.82bn
- $1.74bn
- $96.21m
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Brief: S&P Dow Jones Indices Freshworks Set To Join S&P Smallcap 600
BioLife Solutions, Inc. reports results for the quarter ended June 30 - Earnings Summary
BioLife Solutions Q2 revenue rises 21% year over year
U.S. RESEARCH ROUNDUP- BioLife Solutions, Gossamer Bio, Intuit
U.S. RESEARCH ROUNDUP-Alphabet, IBM, Tesla
Brief: Biolife Solutions Co May Be Required To Pay Repligen Termination Fee Of $59 Million, If Deal Terminates Under Certain Circumstances- SEC Filing
Deals of the day-Mergers and acquisitions
U.S. STOCKS ON THE MOVE-Wabtec, Chubb, CME Group
U.S. STOCKS ON THE MOVE-Wabtec, Johnson & Johnson, CME Group
U.S. STOCKS ON THE MOVE-GE Vernova, Arrowhead Pharma
BioLife climbs after agreeing to be bought by Repligen in $1.5 billion deal
Deals of the day-Mergers and acquisitions
U.S. STOCKS ON THE MOVE-AT&T, Cal-Maine Foods, OraSure Technologies
Brief: Repligen To Acquire Biolife Solutions, Expanding Its Cell Therapy Capabilities With Market Leading Biopreservation Media
BioLife Solutions climbs on $1.5 billion Repligen buyout
Repligen beefs up cell therapy business with $1.5 billion deal for BioLife (updated)
Repligen to buy BioLife Solutions in $1.5 billion deal